Update on calciphylaxis etiopathogenesis, diagnosis, and management.
暂无分享,去创建一个
L. Strowd | A. Ortega‐Loayza | D. Kroshinsky | A. Dominguez | R. Micheletti | J. Keller | Urmi Khanna
[1] R. Thadhani,et al. Calciphylaxis in Patients With Normal Renal Function: A Case Series and Systematic Review , 2018, Mayo Clinic proceedings.
[2] J. Buades,et al. SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels , 2018, Journal of Nephrology.
[3] P. Senet,et al. Calciphylaxis in haemodialysed patients: diagnostic value of calcifications in cutaneous biopsy , 2018, The British journal of dermatology.
[4] D. Christiadi,et al. Calciphylaxis in a dialysis patient successfully treated with high-dose vitamin K supplementation , 2017, Clinical kidney journal.
[5] J. Strand,et al. Underreported use of palliative care and patient‐reported outcome measures to address reduced quality of life in patients with calciphylaxis: a systematic review , 2017, The British journal of dermatology.
[6] C. Lohse,et al. Histopathology of Calciphylaxis: Cohort Study With Clinical Correlations , 2017, The American Journal of dermatopathology.
[7] S. Booth,et al. Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis. , 2017, Journal of the American Society of Nephrology : JASN.
[8] J. Floege,et al. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] C. Rabito,et al. The Role of Bone Scintigraphy in the Diagnosis of Calciphylaxis , 2017, JAMA dermatology.
[10] A. Weaver,et al. Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis. , 2016, Mayo Clinic proceedings.
[11] R. Thadhani,et al. Calciphylaxis in peritoneal dialysis patients: a single center cohort study , 2016, International journal of nephrology and renovascular disease.
[12] R. Nair,et al. Advanced-stage calciphylaxis: Think before you punch , 2016, Cleveland Clinic Journal of Medicine.
[13] R. Thadhani,et al. A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors. , 2016, Journal of the American Society of Nephrology : JASN.
[14] A. Dominguez,et al. Calciphylaxis: Controversies in Pathogenesis, Diagnosis and Treatment , 2016, The American journal of the medical sciences.
[15] Janet M. Davis. The Relationship Between Obesity and Calciphylaxis: A Review of the Literature. , 2016, Ostomy/Wound Management.
[16] P. Nagpal,et al. Gastrointestinal Bleeding Secondary to Calciphylaxis , 2015, The American journal of case reports.
[17] S. Nigwekar,et al. Multidisciplinary approach to calcific uremic arteriolopathy , 2015, Current opinion in nephrology and hypertension.
[18] M. Kamdar,et al. Calciphylaxis: risk factors, diagnosis, and treatment. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] C. Vermeer,et al. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[20] N. Chen,et al. Adipocyte induced arterial calcification is prevented with sodium thiosulfate. , 2014, Biochemical and biophysical research communications.
[21] B. Astor,et al. Pilot Study of the Effect of Lanthanum Carbonate (Fosrenol®) In Patients with Calciphylaxis: A Wisconsin Network for Health Research (WiNHR) Study , 2014, Journal of nephrology & therapeutics.
[22] C. Chao,et al. Tumoral calcinosis in renal failure. , 2014, QJM : monthly journal of the Association of Physicians.
[23] M. Hoang,et al. Cutaneous Calciphylaxis: A Retrospective Histopathologic Evaluation , 2013, The American Journal of dermatopathology.
[24] K. Mahaffey,et al. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. , 2012, The New England journal of medicine.
[25] R. Weenig,et al. Net-like pattern of calcification on plain soft-tissue radiographs in patients with calciphylaxis. , 2012, Journal of the American Academy of Dermatology.
[26] A. Fine,et al. Calciphylaxis: The Beginning of the End? , 2008, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[27] M. Pittelkow,et al. Calciphylaxis: natural history, risk factor analysis, and outcome. , 2007, Journal of the American Academy of Dermatology.
[28] P. Coates,et al. VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE: Calcific Uremic Arteriolopathy: Advances in Pathogenesis and Treatment , 2007 .
[29] M. Ashby,et al. Symptomatic management of calciphylaxis: a case series and review of the literature. , 2006, Journal of pain and symptom management.
[30] D. Spector,et al. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[31] J. Dear,et al. Calciphylaxis , 2003, The Lancet.
[32] A. Schwarz,et al. The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification , 2003 .
[33] A. Fine,et al. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. , 2002, Kidney international.
[34] A. Evan,et al. Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[35] W. White,et al. A case control study of proximal calciphylaxis. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[36] R. Behringer,et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein , 1997, Nature.
[37] G. Burg,et al. Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic renal failure and benefit from parathyroidectomy. , 1995, Journal of the American Academy of Dermatology.
[38] C. Edelstein,et al. Systemic calciphylaxis presenting as a painful, proximal myopathy. , 1992, Postgraduate medical journal.